Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/134579
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHorna, Gertrudis-
dc.contributor.authorLópez, María-
dc.contributor.authorGuerra, Humberto-
dc.contributor.authorSáenz, Yolanda-
dc.contributor.authorRuiz, Joaquim-
dc.date.accessioned2019-06-05T14:11:50Z-
dc.date.available2019-06-05T14:11:50Z-
dc.date.issued2018-11-07-
dc.identifier.issn2045-2322-
dc.identifier.urihttps://hdl.handle.net/2445/134579-
dc.description.abstractMexAB-OprM and MexEF-OprN are Pseudomonas aeruginosa efflux pumps involved in the development of antibiotic resistance. Several studies developed with laboratory strains or using a few clinical isolates have reported that the regulation system of MexEF-OprN is involved in the final levels of MexAB-OprM expression. Therefore, this study was aimed to determine the interplay between MexAB-OprM and MexEF-OprN in 90 out of 190 P. aeruginosa clinical isolates with an efflux pump overexpression phenotype. Regarding oprD, 33% (30/90) of isolates displayed relevant modifications (RM) defined as frameshift or premature stop, both related to carbapenem resistance. On the other hand, 33% of the isolates displayed RM in nalC, nalD or mexR, which were significantly associated with multidrug resistance (MDR), non-susceptibility to carbapenems, OprD alterations and strong biofilm production. Meanwhile, the RM in MexS were associated with presence of pigment (p = 0.004). Otherwise, when all the regulators were analysed together, the association between RM in MexAB-OprM regulators and MDR was only significant (p = 0.039) when mexS was the wild type. These data show the modulatory effect of MexEF-OprN on MexAB-OprM in a clinical population of P. aeruginosa. Further studies may contribute to design of novel molecules acting on this interplay to fight against antimicrobial resistance.-
dc.format.extent11 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.1038/s41598-018-34694-z-
dc.relation.ispartofScientific Reports, 2018, vol. 8-
dc.relation.urihttp://dx.doi.org/10.1038/s41598-018-34694-z-
dc.rightscc by (c) Horna et al., 2018-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/-
dc.sourceArticles publicats en revistes (ISGlobal)-
dc.subject.classificationPseudomonas-
dc.subject.classificationResistència als medicaments-
dc.subject.otherDrug resistance-
dc.titleInterplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2019-05-27T08:59:38Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid30405166-
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Horna_G_Sci_Rep_2018.pdf1.57 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons